Los Angeles Rams’ My Cause My Cleats in partnership with Novartis. Players, coaches and staff to wear custom cleats ...
Dr Moni Abraham Kuriakose –co-founder, medical director, and CEO of Karkinos Kerala – is a leading surgical oncologist and ...
There have never been more supplements lining supermarket shelves as millions endeavour to boost their health through a ...
Calvià is preparing for a major year of transformation in 2026, aligned with the Balearic Islands’ wider cultural, ...
The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...
Brisbane-based Freenome has locked in a second major partnership for its blood-based cancer screening test, this time with a ...
MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
Las Vegas has seen a drop in visitors.Many resort casino operators, including Caesars and MGM, have stepped up their ...
MP Materials stock jumped 8% on Nov. 19. This movement extended a week of gains as geopolitical maneuvering around rare earth ...
The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...
Everyday Health on MSN
GLP-1 Drugs Like Ozempic May Boost Colon Cancer Survival
People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results